Bank Of New York Mellon Corp 2seventy Bio, Inc. Transaction History
Bank Of New York Mellon Corp
- $541 Trillion
- Q4 2024
A detailed history of Bank Of New York Mellon Corp transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 154,385 shares of TSVT stock, worth $407,576. This represents 0.0% of its overall portfolio holdings.
Number of Shares
154,385
Previous 158,792
2.78%
Holding current value
$407,576
Previous $749 Million
39.44%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding TSVT
# of Institutions
127Shares Held
44.8MCall Options Held
17.3KPut Options Held
2.9K-
Kynam Capital Management, LP Princeton, NJ5.95MShares$15.7 Million1.11% of portfolio
-
Goldman Sachs Group Inc New York, NY4.29MShares$11.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$9.93 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$9.67 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.92MShares$7.7 Million0.0% of portfolio
About 2seventy bio, Inc.
- Ticker TSVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,873,600
- Market Cap $100M
- Description
- 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...